Form 4: Lemaitre Vascular Inc. Executive Trent G. Kamke Reports Stock Transactions
SEC Form 4
Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, reports exercising stock options and selling shares on August 5, 2024.
Summary
- On August 5, 2024, Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., exercised stock options to acquire 182 shares of common stock at a price of $31.30.
- Simultaneously, Kamke sold 182 shares of common stock at a price of $81.82.
- Following these transactions, Kamke directly owns 4,561 shares of Lemaitre Vascular Inc.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock option exercises and sales. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive sentiment and potential alignment with shareholder interests.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares and potentially influencing the stock price.
Key Dates
| Date | Description |
|---|---|
| 12/22/2017 | Date the stock option was granted. |
| 08/05/2024 | Date of stock option exercise and sale of shares. |
| 12/22/2024 | Expiration date of the stock option. |
| 08/07/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.